Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ORC1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | ATAD3B | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | RAB33A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | LANCL3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | BPNT1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | ANP32E | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | MMP24 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | PCDHB9 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | ASZ1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | MORC3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |